Episode 27:
PTSD Treatment with MDMA


MDMA has shown to be a promising drug for treating individuals with chronic Post Traumatic Stress Disorder (PTSD) when used as an adjunct to psychotherapy. Tune in to learn more about how this drug can help treat those with PTSD. 

This episode was produced as part of an upper level course on Neuropharmacology taught by Angel Kaur during Fall 2016 at UNC Asheville.

Club Kaur
Club Kaur
27. PTSD Treatment with MDMA

Articles Referenced

  • Danforth, A.L.; Struble, C.M.; Yazar-Klosinski, B.; Grob, C.S. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults. Progress in Neuro- Pyschopharmacology & Biological Psychiatry 2016, 64, 237-249.
  • Mithoefer, M.C.; Wagner, M.T.; Mithoefer, A.T.; Jerome, L.; Doblin, R. The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology 2011, 25, 439-452.
  • Mithoefer, M.C.; Wagner, M.T.; Mithoefer, A.T.; Jerome, L.; Martin, S.F.; Yazar-Klosinski, B.; Michel, Y.; Brewerton, T.D.; Doblin, R. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4- methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology 2014, 27, 28-39.

Related Reading


Written, Directed by: Haley Enten
Featuring: Haley Enten, Julia Fields
Scientific Research by: Haley Enten
Recorded, Edited by: Matthew Bailey

Additional Sound EngineeringCat Sawyer

New episodes

New episodes arrive every third Tuesday

Have a science question?